Cresco Labs (FRA:6CQ) E10: €-0.67 (As of Mar. 2026)


FRA:6CQ Cresco Labs Inc FRA:6CQ
43 GF Score
Price €0.67
GF Value €0.88
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cresco Labs E10?

Cresco Labs FRA:6CQ -4.03% 43 E10 is €-0.67 as of Mar. 2026. GuruFocus rates FRA:6CQ with a GF Score™ of 43/100 and a GF Value™ of €0.88 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cresco Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.035. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.67 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 14.30% per year. During the past 5 years, the average E10 Growth Rate was 33.00% per year. During the past 10 years, the average E10 Growth Rate was 37.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cresco Labs was 58.30% per year. The lowest was 4.30% per year. And the median was 20.40% per year.

As of today (2026-06-30), Cresco Labs's current stock price is €0.666. Cresco Labs's E10 for the quarter that ended in Mar. 2026 was €-0.67. Cresco Labs's Shiller PE Ratio of today is .


Cresco Labs  (FRA:6CQ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cresco Labs E10 Related Terms


Cresco Labs E10 Historical Data

* Premium members only.

The historical data trend for Cresco Labs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs E10 Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.11 -1.62 -1.23 -0.74 -0.83

Cresco Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.70 -0.54 -0.91 -0.83 -0.67

FRA:6CQ vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Shiller PE Ratio falls into.


FRA:6CQ
43GF Score
Cresco Labs Inc FRA:6CQ
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cresco Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.035/330.2130*330.2130
=-0.035

Current CPI (Mar. 2026) = 330.2130.

Cresco Labs Quarterly Data

per share eps CPI Adj_EPS
201604 -0.382 239.261 -0.527
201607 -0.477 240.628 -0.655
201610 -0.211 241.729 -0.288
201701 -1.835 242.839 -2.495
201704 -0.352 244.524 -0.475
201707 -0.412 244.786 -0.556
201710 -0.323 246.663 -0.432
201801 -1.141 247.867 -1.520
201804 -0.486 250.546 -0.641
201807 2.828 252.006 3.706
201810 -0.579 252.885 -0.756
201903 -0.044 254.202 -0.057
201906 -0.018 256.143 -0.023
201909 -0.054 256.759 -0.069
201912 -0.216 256.974 -0.278
202003 -0.118 258.115 -0.151
202006 -0.160 257.797 -0.205
202009 0.034 260.280 0.043
202012 -0.214 260.474 -0.271
202103 -0.101 264.877 -0.126
202106 -0.017 271.696 -0.021
202109 -0.850 274.310 -1.023
202112 -0.027 278.802 -0.032
202203 -0.082 287.504 -0.094
202206 -0.047 296.311 -0.052
202209 -0.030 296.808 -0.033
202212 -0.510 296.797 -0.567
202303 -0.084 301.836 -0.092
202306 -0.111 305.109 -0.120
202309 -0.319 307.789 -0.342
202312 0.013 306.746 0.014
202403 -0.018 312.332 -0.019
202406 -0.149 314.175 -0.157
202409 -0.027 315.301 -0.028
202412 0.001 315.605 0.001
202503 -0.037 319.799 -0.038
202506 -0.043 322.561 -0.044
202509 -0.043 324.800 -0.044
202512 -0.205 324.054 -0.209
202603 -0.035 330.213 -0.035

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.67 mean?
Cresco Labs (FRA:6CQ) has a E10 of €-0.67 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cresco Labs and its competitors.
Is Cresco Labs' E10 too high?
Cresco Labs' current E10 is €-0.67. Overall, Cresco Labs has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cresco Labs' E10 compare to ZTS and UTHR?
Cresco Labs' E10 of €-0.67 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cresco Labs and its competitors. Cresco Labs's current E10 is €-0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cresco Labs stock overvalued right now?
Based on GuruFocus' analysis, Cresco Labs (FRA:6CQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.88, compared to a current price of €0.67 — trading 24.3% below its estimated fair value. The current E10 is €-0.67. Cresco Labs' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Cresco Labs (FRA:6CQ), the current E10 is €-0.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cresco Labs (FRA:6CQ) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of €0.67 is trading 24.3% below its estimated GF Value™ of €0.88. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for FRA:6CQ:

  • E10: €-0.67
  • GF Value™: €0.88 vs. price of €0.67 (24.3% below fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the FRA:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
43GF Score

Get the complete analysis for FRA:6CQ

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.67
Price
€0.88
GF Value